JJP-10 is a statin currently being researched on its efficacy in reducing low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides. The rational design of JJP-10 is anticipated to reduce the problems associated with the currently marketed products, the general class of statins, and potential toxicities such as fatal rhabdomyolysis, kidney problems, liver problems, and muscle fatigue. Some of these side effects are caused by the presense of a certain chemical structure. JJP-10 does not have this chemical structure, thus eliminating the renal and myopathic toxicities associated with most statins.
JJP-11 is currently being researched on its efficacy to boost high-density lipoprotein cholesterol (HDL-C), aka "Good Choleserol" levels.
JJP-12 is currently being researched on its efficacy to boost high-density lipoprotein cholesterol (HDL-C), aka "Good Choleserol" levels. .
Preliminary animal studies have already proven the effectiveness of JJP-10, JJP-11, and JJP-12.
Copyright © JJ Pharma, Inc.
Template By Zymic.com